| Group A ( n  = 44) | Group B ( n  = 45) | P value | ||
---|---|---|---|---|---|
No | % | No | % | ||
LM | |||||
 Non significance | 44 | 100.0% | 45 | 100.0% |  |
 Significant lesion | 0 | 0.0% | 0 | 0.0% | – |
 Culprit lesion | 0 | 0.0% | 0 | 0.0% |  |
LAD | |||||
 No significance | 9 | 20.5% | 4 | 8.9% |  |
 Significant lesion | 0 | 0.0% | 7 | 15.6% | 0.189 |
 Culprit lesion | 34 | 77.3% | 34 | 75.6% |  |
Diagonal | |||||
 Non significance | 43 | 97.7% | 38 | 84.4% |  |
 Significant lesion | 0 | 0.0% | 7 | 15.6% | 0.016* |
 Culprit lesion | 1 | 2.3% | 0 | 0.0% |  |
LCX | |||||
 Non significance | 43 | 97.7% | 33 | 73.3% |  |
 Significant lesion | 0 | 0.0% | 10 | 22.2% | 0.003* |
 Culprit lesion | 1 | 2.3% | 2 | 4.4% |  |
Ramus | |||||
 Non significance | 3 | 100.0% | 3 | 60.0% |  |
 Significant lesion | 0 | 0.0% | 2 | 40.0% | 0.464 |
 Culprit lesion | 0 | 0.0% | 0 | 0.0% |  |
RCA | |||||
 Non significance | 37 | 84.1% | 15 | 33.3% |  |
 Significant lesion | 0 | 0.0% | 22 | 48.9% | 0.193 |
 Culprit lesion | 8 | 18.1% | 8 | 17.8% |  |
PDA | |||||
 Non significance | 44 | 100.0% | 0 | 0.0% |  |
 Significant lesion | 0 | 0.0% | 45 | 100.0% | – |
 Culprit lesion | 0 | 0.0% | 0 | 0.0% |  |
OM | |||||
 Non significance | 43 | 97.7% | 35 | 77.8% |  |
 Significant lesion | 0 | 0.0% | 9 | 20.0% | 0.016* |
 Culprit lesion | 0 | 0.0% | 1 | 2.2% |  |
Culprit lesion | |||||
 LAD | 34 | 77.3% | 34 | 75.6% |  |
 LAD-Diagonal | 0 | 0.0% | 1 | 2.2% |  |
 RCA | 8 | 18.1% | 7 | 15.6% | 0.633 |
 LCX | 1 | 2.3% | 2 | 4.4% |  |
 OM | 0 | 0.0% | 1 | 2.2% |  |
 Diagonal | 1 | 2.3% | 0 | 0.0% |  |